These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12824914)

  • 1. Regulation of TGF-beta signaling and its roles in progression of tumors.
    Miyazono K; Suzuki H; Imamura T
    Cancer Sci; 2003 Mar; 94(3):230-4. PubMed ID: 12824914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta/SMAD signaling and its involvement in tumor progression.
    Miyazono K
    Biol Pharm Bull; 2000 Oct; 23(10):1125-30. PubMed ID: 11041237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SnoN in TGF-beta signaling and cancer biology.
    Pot I; Bonni S
    Curr Mol Med; 2008 Jun; 8(4):319-28. PubMed ID: 18537639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta signaling by Smad proteins.
    Miyazono K; ten Dijke P; Heldin CH
    Adv Immunol; 2000; 75():115-57. PubMed ID: 10879283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
    Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
    Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.
    Yang J; Zhang X; Li Y; Liu Y
    J Am Soc Nephrol; 2003 Dec; 14(12):3167-77. PubMed ID: 14638915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of TGF-beta signaling by Smad7.
    Yan X; Liu Z; Chen Y
    Acta Biochim Biophys Sin (Shanghai); 2009 Apr; 41(4):263-72. PubMed ID: 19352540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
    Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
    Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration.
    Macias-Silva M; Li W; Leu JI; Crissey MA; Taub R
    J Biol Chem; 2002 Aug; 277(32):28483-90. PubMed ID: 12023281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transforming growth factor-beta signaling and cancer].
    Miyazono K
    Hum Cell; 2000 Sep; 13(3):97-101. PubMed ID: 11197777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling.
    Nagano Y; Mavrakis KJ; Lee KL; Fujii T; Koinuma D; Sase H; Yuki K; Isogaya K; Saitoh M; Imamura T; Episkopou V; Miyazono K; Miyazawa K
    J Biol Chem; 2007 Jul; 282(28):20492-501. PubMed ID: 17510063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
    Baldwin RL; Tran H; Karlan BY
    Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of transforming growth factor-beta signaling.
    Zhu HJ; Burgess AW
    Mol Cell Biol Res Commun; 2001 Nov; 4(6):321-30. PubMed ID: 11703090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossing Smads.
    Wrana JL
    Sci STKE; 2000 Mar; 2000(23):re1. PubMed ID: 11752591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad regulation in TGF-beta signal transduction.
    Moustakas A; Souchelnytskyi S; Heldin CH
    J Cell Sci; 2001 Dec; 114(Pt 24):4359-69. PubMed ID: 11792802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMAD7: a timer of tumor progression targeting TGF-β signaling.
    Luo L; Li N; Lv N; Huang D
    Tumour Biol; 2014 Sep; 35(9):8379-85. PubMed ID: 24935472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
    He J; Tegen SB; Krawitz AR; Martin GS; Luo K
    J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads.
    Park SH
    J Biochem Mol Biol; 2005 Jan; 38(1):9-16. PubMed ID: 15715940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma.
    Fukuchi M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Sohda M; Manda R; Tsukada K; Kato H; Kuwano H
    Int J Cancer; 2004 Mar; 108(6):818-24. PubMed ID: 14712482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.